Global X Genomics & Biotechnology ETF
GNOM
65 hedge funds and large institutions have $35.2M invested in Global X Genomics & Biotechnology ETF in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 21 reducing their positions, and 7 closing their positions.
18% more capital invested
Capital invested by funds: $29.9M → $35.2M (+$5.27M)
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
2.62% more ownership
Funds ownership: 7.86% → 10.48% (+2.6%)
0% more funds holding
Funds holding: 65 → 65 (0)
19% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KF
Krilogy Financial
St. Louis,
Missouri
|
+$1.24M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$1.09M |
| 3 |
FTUS
Flow Traders U.S.
New York
|
+$929K |
| 4 |
OCM
One Capital Management
Westlake Village,
California
|
+$555K |
| 5 |
Two Sigma Investments
New York
|
+$548K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SA
Sanctuary Advisors
Indianapolis,
Indiana
|
-$590K |
| 2 |
Mirae Asset Global ETFs Holdings
Causeway Bay,
Hong Kong
|
-$581K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$357K |
| 4 |
Jane Street
New York
|
-$185K |
| 5 |
Lido Advisors
Los Angeles,
California
|
-$178K |
GNOM Hedge Fund Activity: Q3 2024 in Review
65 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Global X Genomics & Biotechnology ETF (GNOM) for Q3 2024, worth a combined $35.2M — up 18% from $29.9M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new GNOM positions and 7 closed out — a net gain of 1 holder — while 17 added to existing stakes and 21 trimmed.
The largest buyer was Krilogy Financial, opening a new position worth an estimated $1.24M. The largest seller was Sanctuary Advisors, exiting entirely with an estimated $590K sold.
- 65 institutional investors held Global X Genomics & Biotechnology ETF (GNOM) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $35.2M of Global X Genomics & Biotechnology ETF stock for Q3 2024, up 18% quarter-over-quarter.
- 8 funds opened new Global X Genomics & Biotechnology ETF positions in Q3 2024 and 7 closed out, a net change of +1 holder.
- The largest Global X Genomics & Biotechnology ETF buyer in Q3 2024 was Krilogy Financial, an estimated $1.24M added.
- The largest Global X Genomics & Biotechnology ETF seller in Q3 2024 was Sanctuary Advisors, an estimated $590K sold.
Based on aggregated 13F filings for Q3 2024.